Market Overview:
Phenylketonuria (PKU) is a rare genetic disorder that affects the body's ability to process an amino acid called phenylalanine. Without treatment, phenylalanine can build up to dangerous levels in the blood and cause cognitive and neurological problems. The market for PKU treatment is growing due to increasing awareness about the condition and advancements in medical research and technology. However, there are still major obstacles in the market, such as limited access ... Read more

The Phenylketonuria Treatment Market is estimated to be valued at US$ 445.8 million in 2023 and is expected to exhibit a CAGR of 11.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

 

Market Overview:

Phenylketonuria (PKU) is a rare genetic disorder that affects the metabolism of phenylalanine, an amino acid found in many ... Read more